A Xanthine, 3,7-dimethyl- CEP of the European Pharmacopoeia monograph is often referred to as a Xanthine, 3,7-dimethyl- Certificate of Suitability (COS). The purpose of a Xanthine, 3,7-dimethyl- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Xanthine, 3,7-dimethyl- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Xanthine, 3,7-dimethyl- to their clients by showing that a Xanthine, 3,7-dimethyl- CEP has been issued for it. The manufacturer submits a Xanthine, 3,7-dimethyl- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Xanthine, 3,7-dimethyl- CEP holder for the record. Additionally, the data presented in the Xanthine, 3,7-dimethyl- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Xanthine, 3,7-dimethyl- DMF.
A Xanthine, 3,7-dimethyl- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Xanthine, 3,7-dimethyl- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Xanthine, 3,7-dimethyl- suppliers with CEP (COS) on PharmaCompass.